So, Edward C.
Zhou, Hua
Greenwell, Ariana
Burch, Erin E.
Ji, Yaping
Mérigeon, Emmanuel Y.
Olsen, Henrik S.
Bentzen, Søren M.
Block, David S.
Zhang, Xiaoyu
Strome, Scott E.
Funding for this research was provided by:
School of Medicine, University of Maryland, Department of Otorhinolaryngology-Head and Neck Surgery
Article History
Received: 9 May 2023
Accepted: 1 June 2023
First Online: 15 June 2023
Declarations
:
: Dr. Scott E. Strome is a Cofounder, stockholder, and paid consultant for Gliknik Inc., a biotechnology company. He also serves on the SAB and holds stock options for Virion Inc. Finally, he receives significant royalties from the Mayo Clinic, for licensed IP surrounding the manipulation of the PD-1:PD-L1 pathway for the treatment of cancer.